tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Novo Nordisk (NVO) Launches Blockbuster Diabetes Drug Ozempic in India
PremiumMarket NewsNovo Nordisk (NVO) Launches Blockbuster Diabetes Drug Ozempic in India
6h ago
FDA speeding review of Eli Lilly’s weight loss pill, Reuters reports
Premium
The Fly
FDA speeding review of Eli Lilly’s weight loss pill, Reuters reports
8h ago
Eli Lilly & Co: Promising Future with Strong TRIUMPH-4 Trial Results and Strategic Pipeline Driving Growth
Premium
Ratings
Eli Lilly & Co: Promising Future with Strong TRIUMPH-4 Trial Results and Strategic Pipeline Driving Growth
9h ago
Morning Movers: Oracle continues to slide despite earnings beat
PremiumThe FlyMorning Movers: Oracle continues to slide despite earnings beat
1d ago
LLY and NOVO: Goldman Sachs Weighs In on the Top Obesity Stocks to Watch in 2026
Premium
Market News
LLY and NOVO: Goldman Sachs Weighs In on the Top Obesity Stocks to Watch in 2026
1d ago
Eli Lilly reports TRIUMPH-4 trial of retatrutide met primary endpoint
Premium
The Fly
Eli Lilly reports TRIUMPH-4 trial of retatrutide met primary endpoint
1d ago
Hims & Hers Health (HIMS) Bolsters UK Business with Launch of Weight-Loss Plans
PremiumMarket NewsHims & Hers Health (HIMS) Bolsters UK Business with Launch of Weight-Loss Plans
2d ago
Eli Lilly price target raised to $1,070 from $850 at HSBC
Premium
The Fly
Eli Lilly price target raised to $1,070 from $850 at HSBC
2d ago
Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
Premium
Market News
Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
3d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100